Solutions
- Research Type
  - Fundamental Equity ResearchGain a comprehensive view of global themes, industries, and companies.
  - ETF Data & AnalyticsThe data and analytics you need to navigate the ETF universe.
  - ETF & Mutual Fund ResearchA forward focused, holistic approach to fund insights.
  - Forensic Accounting ResearchUnderstand implications of public company financial reporting.
  - Public Policy ResearchIdentify opportunity and risks driven by public policy.
  - Technical ResearchGiving you confidence to navigate any market cycle.
  - Legal ResearchReal-time insights on legal themes, cases, and regulatory events.
- Client Type
  - Wealth ManagementFull-service Broker-Dealers, Online Broker-Dealers, Wealth Management Firms, Private Banks, RIAs
  - Institutional InvestorsHedge Funds, Asset Managers, Pension Funds, Sovereign Wealth Funds, Private Equity, Family Offices
  - Financial AdvisorsFinancial Advisors, Relationship Managers, Wealth Managers
  - Individual InvestorsSelf-directed individual investors
Insights
About CFRA
Login

Solutions
- Research Type
  - Fundamental Equity ResearchGain a comprehensive view of global themes, industries, and companies.
  - ETF Data & AnalyticsThe data and analytics you need to navigate the ETF universe.
  - ETF & Mutual Fund ResearchA forward focused, holistic approach to fund insights.
  - Forensic Accounting ResearchUnderstand implications of public company financial reporting.
  - Public Policy ResearchIdentify opportunity and risks driven by public policy.
  - Technical ResearchGiving you confidence to navigate any market cycle.
  - Legal ResearchReal-time insights on legal themes, cases, and regulatory events.
- Client Type
  - Wealth ManagementFull-service Broker-Dealers, Online Broker-Dealers, Wealth Management Firms, Private Banks, RIAs
  - Institutional InvestorsHedge Funds, Asset Managers, Pension Funds, Sovereign Wealth Funds, Private Equity, Family Offices
  - Financial AdvisorsFinancial Advisors, Relationship Managers, Wealth Managers
  - Individual InvestorsSelf-directed individual investors
Insights
About CFRA
Login

Research, Policy

FDA Action on Aspartame Unlikely

Ira S. Loss, Executive Vice President & Health Care Analyst

Ryan Visnovec, Research Assistant

12 July 2023

Summary

Recent reports that the World Health Organization (WHO) will reclassify aspartame as “possibly carcinogenic to humans” on July 14 has once again thrust questions about the safety of the additive into the spotlight. We believe it is highly unlikely the FDA will do anything to alter its status on the Generally Recognized as Safe (GRAS) list.

Want to learn more? Download the Report.

Solutions

Public Policy Research

Identify opportunity and risks driven by public policy.

Related Insights

Mitigation Expectations for Medicare Advantage Rate Notice

Size of Medicare Advantage mitigation may be less than earlier expectations...